<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Perosa V</submitter><funding>Alzheimer's Association</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>156</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12265290</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>The medial temporal lobe (MTL) is strategically important for cognition and the pathogenesis of Alzheimer's Disease (AD). Cerebral small vessel disease (CSVD) independently contributes to cognitive impairment and is believed to play a role in AD. CSVD and proteinopathies related to AD often coexist in the MTL but neither the severity of CSVD, nor the associations between these pathologies have been quantitatively addressed in this brain region. We hypothesized that the severity of CSVD in the MTL is associated with the local burden of proteinopathies implicated in neurodegeneration (tau-tangles, amyloid-β-plaques, phospho-Tar-DNA-Binding-Protein-43 [pTDP-43]), regardless of disease stage. One potential mechanism linking CSVD and proteinopathies is a failure in perivascular brain clearance.</pubmed_abstract><journal>Acta neuropathologica communications</journal><pubmed_title>Relationship between cerebral small vessel disease and proteinopathies in the medial temporal lobe.</pubmed_title><pmcid>PMC12265290</pmcid><funding_grant_id>T32 GM144273</funding_grant_id><funding_grant_id>R00AG059893</funding_grant_id><funding_grant_id>K99AG080134</funding_grant_id><funding_grant_id>243291</funding_grant_id><pubmed_authors>van den Berg ML</pubmed_authors><pubmed_authors>van Veluw SJ</pubmed_authors><pubmed_authors>Connors T</pubmed_authors><pubmed_authors>Rotta J</pubmed_authors><pubmed_authors>Bax F</pubmed_authors><pubmed_authors>Oltmer J</pubmed_authors><pubmed_authors>Auger CA</pubmed_authors><pubmed_authors>Augustinack J</pubmed_authors><pubmed_authors>Perbet R</pubmed_authors><pubmed_authors>Greenberg SM</pubmed_authors><pubmed_authors>Hyman BT</pubmed_authors><pubmed_authors>Perosa V</pubmed_authors><pubmed_authors>Frosch MP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Relationship between cerebral small vessel disease and proteinopathies in the medial temporal lobe.</name><description>The medial temporal lobe (MTL) is strategically important for cognition and the pathogenesis of Alzheimer's Disease (AD). Cerebral small vessel disease (CSVD) independently contributes to cognitive impairment and is believed to play a role in AD. CSVD and proteinopathies related to AD often coexist in the MTL but neither the severity of CSVD, nor the associations between these pathologies have been quantitatively addressed in this brain region. We hypothesized that the severity of CSVD in the MTL is associated with the local burden of proteinopathies implicated in neurodegeneration (tau-tangles, amyloid-β-plaques, phospho-Tar-DNA-Binding-Protein-43 [pTDP-43]), regardless of disease stage. One potential mechanism linking CSVD and proteinopathies is a failure in perivascular brain clearance.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-03-18T13:57:14.343Z</modification><creation>2025-08-27T03:06:55.269Z</creation></dates><accession>S-EPMC12265290</accession><cross_references><pubmed>40671047</pubmed><doi>10.1186/s40478-025-02076-y</doi></cross_references></HashMap>